Saving Human Lives

One At a Time

Enzychem Lifesciences Corporation is a Global New Drug Development company that was founded on the most advanced..

Read More
Clinical Pipeline

Clinical Pipeline

One deep-rooted belief we hold here at Enzychem Lifesciences is that any form of treatment should be accessible to patients all over the world. As we pursue to develop a global new drug, our team carries the important duty of ensuring EC-18’s efficacy backed up by comprehensive studies. Enzychem has commenced clinical trials in 2016, and since then, we have been conducting ongoing research in the drug’s effects on patients with one of various conditions.

Read More
Clinical Program

Clinical Program

The global drug development program at Enzychem entails an extensive sequence of clinical studies on the safety and efficacy of EC-18 in various indications.

Read More

Latest News

(2018-03-07 09:28:19 Enzychem Lifesciences Annual General Meeting of Shareholders (2018) Read More
(2018-01-23 09:11:37 Enzychem’s KOSDAQ listing sees strong demand Read More
(2018-01-22 09:15:29 Orphan Drug Designation Granted to Potential Acute Radiation Syndrome Treatment Read More
(2018-01-22 04:59:54 生物技术公司Enzychem Lifesciences最近宣布,美国FDA已经同意授予公司开发的EC-18罕见病疗法认证。该疗法主要是用于治疗一种名为急性辐射综合症的罕见病。 Read More